Programme

March 11 download agenda
8:15-09:00
Registration
09:00-09:30
Opening Presentation

Analytical overview: existing market opportunities for pharmaceutical products globally; key trends and challenges

 

09:30-11:00
Session One: Portfolio Management
  • Approaches to new product selection and pipeline prioritisation; portfolio alignment strategies
  • In-house vs Partnerships; Practical examples of developing a pipeline
  • Cross-border product portfolio adaptation
  • Organisational decision making and resources allocation between projects, markets and products
11:30-12:00
Coffee and Networking Break
12:00-13:15
Session Two: Spotlight on Off-Patent Markets: Strategies, Opportunities and Market Trends
  • Generics: targeting Cancers, Diabetes and Cardio-Vascular diseases – an overview of the market dynamics and global medical needs; how is the pricing and competitive pressure affecting the industry globally
  • Branded generics: an overview of the markets that are dominated by branded originator drugs? Where are the opportunities globally?
  • Value-added generics: an overview of the market potential and partnership opportunities
  • Integrating API and final-dosage manufacturing – will we witness more API players on generics market? what are the opportunities for niche generics?
13.15-14:15
Lunch
14:15-15:30
Session Three: Business Development – Global Landscape and Practicalities
  • Partner selection in strategic alliances: key approaches, strategies and short-term considerations
  • Distribution agreements: financial, commercial and geo-considerations
  • Specific approaches to partnering arrangements; valuation of licensing deals and agreement structures
15:30-16:00
Coffee and Networking break
16:00-19:00
Networking Session

Pre-arranged 1-2-1 meetings with 100 delegates over delegates from 20+ countries

19:00-21:00
Cocktail
March 12 download agenda
09:30-10:30
Session Four: Middle-Size Pharma: Think Global, Act Global

In association with Europharm

This spotlight session will address key issues that the middle-size pharmas are facing when it comes to providing value to the patients in Europe and beyond. The session will consider SMEs’ efforts in tackling the new commercial and regulatory challenges will discuss why national and international associations are perfectly placed to engage with the key stakeholders

10:30-11:30
Session Five: Case Studies

The session will offer practical cases of market entries and examples of the companies’ expansion globally. Several countries and regions will be discussed in-depth: China, GCC, CIS, CEE, Algeria, Brazil, Vietnam etc.

11:30–12:00
Coffee and Networking
12:00-13:30
Session Six: Product Approvals

The session will give an overview of drug registration requirements for pharmaceuticals in the emerging markets and will consider the key regulatory barriers impacting the product approvals in APAC, CIS, GCC and LatAm.

13:30-14:30
Lunch
14:30-15:30
Session Seven: International Supply Chain
  • CDMO and CMO: Assessing the future of outsourcing model and the role of contract manufacturers in supporting international pharma growth
  • Meeting the supply chain challenges: implementing the new serialisation requirements
  • Embracing the Digital Industry 4.0 transformation
15:30-16:00
Coffee and Networking
16:30-18:30
One-to-One Meetings Continue